1168PTrastuzumab plus docetaxel in patients with advanced HER2-positive salivary duct carcinoma: Exploratory biomarker analyses
Takahashi, H, Kawakita, D, Fushimi, C, Nagao, T, Hirai, H, Saigusa, N, Masubuchi, T, Matsuki, T, Okada, T, Baba, D, Miura, K, Saotome, T, Tada, YVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz252.060
Date:
October, 2019
File:
PDF, 75 KB
2019